A. Villani

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi et al. · The Lancet · 2023 · 302 citations

Life Sciences, Immunology, Pharmacotherapy +6

French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults

F. Amatore, A. Villani, M. Tauber et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 223 citations · Full text

Medicine, Clinical Sciences, Dermatology +9

GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis

M. Larsabal, S. Ly, É. Sbidian et al. · British Journal of Dermatology · 2018 · 78 citations

Medicine, Dermatology, Andrology +9

Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases

Coline Faivre, A. Villani, F. Aubin et al. · Journal of the American Academy of Dermatology · 2016 · 71 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +11

Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US

John R Ingram, Vincenzo Bettoli, J.I. Espy et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 48 citations · Full text

Medicine, Dermatology, Dermatopathology +14